{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T01:50:22Z","timestamp":1780624222392,"version":"3.54.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2011,8,22]],"date-time":"2011-08-22T00:00:00Z","timestamp":1313971200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1038\/aps.2011.83","type":"journal-article","created":{"date-parts":[[2011,8,24]],"date-time":"2011-08-24T11:11:46Z","timestamp":1314184306000},"page":"1215-1224","source":"Crossref","is-referenced-by-count":13,"title":["Pharmacological mechanisms underlying the antinociceptive and tolerance effects of the 6,14-bridged oripavine compound 030418"],"prefix":"10.1038","volume":"32","author":[{"given":"Quan","family":"Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-lei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-di","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze-hui","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,8,22]]},"reference":[{"key":"BFaps201183_CR1","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1002\/1097-0142(19951001)76:7<1283::AID-CNCR2820760728>3.0.CO;2-0","volume":"76","author":"NJ Cherny","year":"1995","unstructured":"Cherny NJ, Chang V, Frager G, Ingham JM, Tiseo PJ, Popp B, et al. Opioid pharmacotherapy in the management of cancer pain: a survey of strategies used by pain physicians for the selection of analgesic drugs and routes of administration. Cancer 1995; 76: 1283\u201393.","journal-title":"Cancer"},{"key":"BFaps201183_CR2","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1126\/science.278.5335.52","volume":"278","author":"GF Koob","year":"1997","unstructured":"Koob GF, Le Moal M . Drug abuse: hedonic homeostatic dysregulation. Science 1997; 278: 52\u20138.","journal-title":"Science"},{"key":"BFaps201183_CR3","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/ana.22002","volume":"67","author":"AC Berger","year":"2010","unstructured":"Berger AC, Whistler JL . How to design an opioid drug that causes reduced tolerance and dependence. Ann Neurol 2010; 67: 559\u201369.","journal-title":"Ann Neurol"},{"key":"BFaps201183_CR4","doi-asserted-by":"publisher","first-page":"3267","DOI":"10.1021\/ja00989a030","volume":"89","author":"KW Bentley","year":"1967","unstructured":"Bentley KW, Hardy DG . Novel analgesics and molecular rearrangements in the morphine-thebaine group. I. Ketones derived from 6,14-endo-ethenotetrahydrothebaine. J Am Chem Soc 1967; 89: 3267\u201373.","journal-title":"J Am Chem Soc"},{"key":"BFaps201183_CR5","doi-asserted-by":"publisher","first-page":"3281","DOI":"10.1021\/ja00989a032","volume":"89","author":"KW Bentley","year":"1967","unstructured":"Bentley KW, Hardy DG . Novel analgesics and molecular rearrangements in the morphine-thebaine group. III. Alcohols of the 6,14-endo-ethenotetrahydrooripavine series and derived analogs of N-allylnormorphine and -norcodeine. J Am Chem Soc 1967; 89: 3281\u201392.","journal-title":"J Am Chem Soc"},{"key":"BFaps201183_CR6","doi-asserted-by":"publisher","first-page":"717","DOI":"10.2174\/1381612043453027","volume":"10","author":"JW Lewis","year":"2004","unstructured":"Lewis JW, Husbands SM . The orvinols and related opioids \u2014 high affinity ligands with diverse efficacy profiles. Curr Pharm Des 2004; 10: 717\u201332.","journal-title":"Curr Pharm Des"},{"key":"BFaps201183_CR7","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1111\/j.1476-5381.1977.tb07532.x","volume":"60","author":"A Cowan","year":"1977","unstructured":"Cowan A, Lewis JW, MacFarlane IR . Agonist and antagonist properties of buprenorphine, a new antinociceptive agent. Br J Pharmacol 1977; 60: 537\u201345.","journal-title":"Br J Pharmacol"},{"key":"BFaps201183_CR8","doi-asserted-by":"publisher","first-page":"168","DOI":"10.3109\/10673229309017075","volume":"1","author":"NK Mello","year":"1993","unstructured":"Mello NK, Mendelson JH, Lukas SE, Gastfriend DR, Teoh SK, Holman BL . Buprenorphine treatment of opiate and cocaine abuse: clinical and preclinical studies. Harv Rev Psychiatry 1993; 1: 168\u201383.","journal-title":"Harv Rev Psychiatry"},{"key":"BFaps201183_CR9","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S0304-3959(97)00040-7","volume":"72","author":"PR Picard","year":"1997","unstructured":"Picard PR, Tramer MR, McQuay HJ, Moore RA . Analgesic efficacy of peripheral opioids (all except intra-articular): a qualitative systematic review of randomised controlled trials. Pain 1997; 72: 309\u201318.","journal-title":"Pain"},{"key":"BFaps201183_CR10","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1046\/j.1360-0443.2001.9656834.x","volume":"96","author":"PG Barnett","year":"2001","unstructured":"Barnett PG, Rodgers JH, Bloch DA . A metaanalysis comparing buprenorphine to methadone for treatment of opiate dependence. Addiction 2001; 96: 683\u201390.","journal-title":"Addiction"},{"key":"BFaps201183_CR11","doi-asserted-by":"publisher","first-page":"3609","DOI":"10.1016\/j.bmcl.2006.02.017","volume":"16","author":"HS Park","year":"2006","unstructured":"Park HS, Lee HY, Kim YH, Park JK, Zvartau EE, Lee H . A highly selective kappa-opioid receptor agonist with low addictive potential and dependence liability. Bioorg Med Chem Lett 2006; 16: 3609\u201313.","journal-title":"Bioorg Med Chem Lett"},{"key":"BFaps201183_CR12","doi-asserted-by":"publisher","first-page":"5176","DOI":"10.1021\/jm070255o","volume":"50","author":"D Rennison","year":"2007","unstructured":"Rennison D, Neal AP, Cami-Kobeci G, Aceto MD, Martinez-Bermejo F, Lewis JW, et al. Cinnamoyl derivatives of 7\u03b1-aminomethyl-6,14-endoethanotetrahydrothebaine and 7\u03b1-aminomethyl-6,14-endoethanotetrahydrooripavine and related opioid ligands. J Med Chem 2007; 50: 5176\u201382.","journal-title":"J Med Chem"},{"key":"BFaps201183_CR13","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1081\/SCC-200050367","volume":"35","author":"CH Liu","year":"2005","unstructured":"Liu CH, Liu H, Han XY, Wu B, Zhong BH, Gong ZH . Synthesis and characterization of thienorphine and its glucuronide conjugate. Synth Commun 2005; 35: 701\u201310.","journal-title":"Synth Commun"},{"key":"BFaps201183_CR14","first-page":"1413","volume":"25","author":"WL Zhao","year":"2004","unstructured":"Zhao WL, Gong ZH, Liang JH . A new buprenorphine analogy, thienorphine, inhibits morphine-induced behavioral sensitization in mice. Acta Pharmacol Sin 2004; 25: 1413\u20138.","journal-title":"Acta Pharmacol Sin"},{"key":"BFaps201183_CR15","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1124\/jpet.105.099937","volume":"318","author":"G Yu","year":"2006","unstructured":"Yu G, Yue YJ, Cui MX, Gong ZH . Thienorphine is a potent long-acting partial opioid agonist: a comparative study with buprenorphine. J Pharmacol Exp Ther 2006; 318: 282\u20137.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFaps201183_CR16","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1124\/jpet.106.113290","volume":"321","author":"JX Li","year":"2006","unstructured":"Li JX, Becker GL, Traynor JR, Gong ZH, France CP . Thienorphine: receptor binding and behavioral effects in rhesus monkeys. J Pharmacol Exp Ther 2006; 321: 227\u201336.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFaps201183_CR17","first-page":"726","volume":"44","author":"G Yu","year":"2009","unstructured":"Yu G, Liu YS, Yan LD, Wen Q, Gong ZH . Structure-activity relationships analysis of thienorphine and its derivatives. Yao Xue Xue Bao 2009; 44: 726\u201330.","journal-title":"Yao Xue Xue Bao"},{"key":"BFaps201183_CR18","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1021\/jm00192a001","volume":"22","author":"GH Loew","year":"1979","unstructured":"Loew GH, Berkowitz DS . Intramolecular hydrogen bonding and conformational studies of bridged thebaine and oripavine opiate narcotic agonists and antagonists. J Med Chem 1979; 22: 603\u20137.","journal-title":"J Med Chem"},{"key":"BFaps201183_CR19","doi-asserted-by":"publisher","first-page":"3154","DOI":"10.1021\/jm00073a015","volume":"36","author":"A Sebastian","year":"1993","unstructured":"Sebastian A, Bidlack JM, Jiang Q, Deecher D, Teitler M, Glick SD, et al. 14 beta-[(p-nitrocinnamoyl)amino]morphinones, 14 beta-[(p-nitrocinnamoyl)amino]-7,8-dihydro-morphinones, and their codeinone analogues: synthesis and receptor activity. J Med Chem 1993; 36: 3154\u201360.","journal-title":"J Med Chem"},{"key":"BFaps201183_CR20","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/S0022-3565(24)36877-6","volume":"282","author":"J Zhu","year":"1997","unstructured":"Zhu J, Luo LY, Chen C, Liu-Chen LY . Activation of the cloned human kappa-opioid receptor by agonists enhances [35S]GTPgammaS binding to membranes: determination of potencies and efficacies of ligands. J Pharmacol Exp Ther 1997; 282: 676\u201368.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFaps201183_CR21","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"MM Bradford","year":"1976","unstructured":"Bradford MM . A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248\u201354.","journal-title":"Anal Biochem"},{"key":"BFaps201183_CR22","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0022-3565(25)03823-6","volume":"72","author":"FE D'Amour","year":"1941","unstructured":"D'Amour FE, Smith DL . A method for determining loss of pain sensation. J Pharmacol Exp Ther 1941; 72: 74\u20139.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFaps201183_CR23","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0022-3565(25)05180-8","volume":"107","author":"NB Eddy","year":"1953","unstructured":"Eddy NB, Leimbach D . Synthetic analgesics. II. Dithienylbutenyl- and dithienylbutylamines. J Pharmacol Exp Ther 1953; 107: 385\u201393.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFaps201183_CR24","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/S0022-3565(25)11434-1","volume":"260","author":"P Horan","year":"1992","unstructured":"Horan P, Taylor J, Yamamura HI, Porreca F . Extremely long-lasting antagonistic actions of nor-binaltorphimine (nor-BNI) in the mouse tail-flick test. J Pharmacol Exp Ther 1992; 260: 1237\u201343.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFaps201183_CR25","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0022-3565(25)12215-5","volume":"275","author":"RM Craft","year":"1995","unstructured":"Craft RM, Henley SR, Haaseth RC, Hruby VJ, Porreca F . Opioid antinociception in a rat model of visceral pain: systemic versus local drug administration. J Pharmacol Exp Ther 1995; 275: 1535\u201342.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFaps201183_CR26","doi-asserted-by":"publisher","first-page":"10331","DOI":"10.1523\/JNEUROSCI.23-32-10331.2003","volume":"23","author":"K Lutfy","year":"2003","unstructured":"Lutfy K, Eitan S, Bryant CD, Yang YC, Saliminejad N, Walwyn W, et al. Buprenorphine-induced antinociception is mediated by mu-opioid receptors and compromised by concomitant activation of opioid receptor-like receptors. J Neurosci 2003; 23: 10331\u20137.","journal-title":"J Neurosci"},{"key":"BFaps201183_CR27","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.neulet.2008.10.065","volume":"448","author":"N Wu","year":"2008","unstructured":"Wu N, Lu XQ, Yan HT, Su RB, Wang JF, Liu Y, et al. Aquaporin 4 deficiency modulates morphine pharmacological actions. Neurosci Lett 2008; 448: 221\u20135.","journal-title":"Neurosci Lett"},{"key":"BFaps201183_CR28","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/j.1476-5381.1969.tb07964.x","volume":"35","author":"WD Paton","year":"1969","unstructured":"Paton WD, Vizi ES . The inhibitory action of noradrenaline and adrenaline on acetylcholine output by guinea-pig ileum longitudinal muscle strip. Br J Pharmacol 1969; 35: 10\u201328.","journal-title":"Br J Pharmacol"},{"key":"BFaps201183_CR29","unstructured":"Bliss CI . Statistics in biology. New York: McGraw-Hill Book Company; 1967."},{"key":"BFaps201183_CR30","doi-asserted-by":"publisher","first-page":"7640","DOI":"10.1523\/JNEUROSCI.20-20-07640.2000","volume":"20","author":"H Ueda","year":"2000","unstructured":"Ueda H, Inoue M, Takeshima H, Iwasawa Y . Enhanced spinal nociceptin receptor expression develops morphine tolerance and dependence. J Neurosci 2000; 20: 7640\u20137.","journal-title":"J Neurosci"},{"key":"BFaps201183_CR31","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1124\/jpet.106.103960","volume":"318","author":"S Chung","year":"2006","unstructured":"Chung S, Pohl S, Zeng J, Civelli O, Reinscheid RK . Endogenous orphanin FQ\/nociceptin is involved in the development of morphine tolerance. J Pharmacol Exp Ther 2006; 318: 262\u20137.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFaps201183_CR32","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1124\/jpet.106.111997","volume":"320","author":"TV Khroyan","year":"2007","unstructured":"Khroyan TV, Zaveri NT, Polgar WE, Orduna J, Olsen C, Jiang F, et al. SR 16435 [1-(1-(bicyclo[3.3.1]nonan-9-yl)piperidin-4-yl)indolin-2-one], a novel mixed nociceptin\/orphanin FQ\/mu-opioid receptor partial agonist: analgesic and rewarding properties in mice. J Pharmacol Exp Ther 2007; 320: 934\u201343.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFaps201183_CR33","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/sj.bjp.0707598","volume":"153","author":"B Spagnolo","year":"2008","unstructured":"Spagnolo B, Calo G, Polgar WE, Jiang F, Olsen CM, Berzetei-Gurske I, et al. Activities of mixed NOP and mu-opioid receptor ligands. Br J Pharmacol 2008; 153: 609\u201319.","journal-title":"Br J Pharmacol"},{"key":"BFaps201183_CR34","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S0014-2999(97)81924-3","volume":"338","author":"MD Aceto","year":"1997","unstructured":"Aceto MD, Harris LS, Bowman ER . Etorphines: mu-opioid receptor-selective antinociception and low physical dependence capacity. Eur J Pharmacol 1997; 338: 215\u201323.","journal-title":"Eur J Pharmacol"},{"key":"BFaps201183_CR35","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1093\/bja\/57.2.192","volume":"57","author":"RA Boas","year":"1985","unstructured":"Boas RA, Villiger JW . Clinical actions of fentanyl and buprenorphine. The significance of receptor binding. Br J Anaesth 1985; 57: 192\u20136.","journal-title":"Br J Anaesth"},{"key":"BFaps201183_CR36","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ejphar.2004.07.097","volume":"499","author":"CL Neilan","year":"2004","unstructured":"Neilan CL, Husbands SM, Breeden S, Ko MC, Aceto MD, Lewis JW, et al. Characterization of the complex morphinan derivative BU72 as a high efficacy, long-lasting mu-opioid receptor agonist. Eur J Pharmacol 2004; 499: 107\u201316.","journal-title":"Eur J Pharmacol"},{"key":"BFaps201183_CR37","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ejphar.2004.12.035","volume":"509","author":"SM Husbands","year":"2005","unstructured":"Husbands SM, Neilan CL, Broadbear J, Grundt P, Breeden S, Aceto MD, et al. BU74, a complex oripavine derivative with potent kappa opioid receptor agonism and delayed opioid antagonism. Eur J Pharmacol 2005; 509: 117\u201325.","journal-title":"Eur J Pharmacol"},{"key":"BFaps201183_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00002826-199302000-00001","volume":"16","author":"GW Pasternak","year":"1993","unstructured":"Pasternak GW . Pharmacological mechanisms of opioid analgesics. Clin Neuropharmacol 1993; 16: 1\u201318.","journal-title":"Clin Neuropharmacol"},{"key":"BFaps201183_CR39","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/S0092-8674(02)00666-9","volume":"108","author":"BL Kieffer","year":"2002","unstructured":"Kieffer BL, Evans CJ . Opioid tolerance \u2014 in search of the holy grail. Cell 2002; 108: 587\u201390.","journal-title":"Cell"},{"key":"BFaps201183_CR40","unstructured":"Hambrook JM, Rance MJ . The interaction of buprenorphine with the opiate receptor: lipophilicity as a determining factor in drug-receptor kinetics. In: Kosterlitz HW, editor. Opiates and endogenous opioid peptides. Amsterdam: Elsevier; 1976. p 295\u2013301."},{"key":"BFaps201183_CR41","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0006-3495(03)74828-0","volume":"84","author":"PJ Woolf","year":"2003","unstructured":"Woolf PJ, Linderman JJ . Untangling ligand induced activation and desensitization of G-protein coupled receptors. Biophys J 2003; 84: 3\u201313.","journal-title":"Biophys J"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/aps201183.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/aps201183","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/aps201183.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,9]],"date-time":"2025-03-09T06:13:20Z","timestamp":1741500800000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/aps201183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,22]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["BFaps201183"],"URL":"https:\/\/doi.org\/10.1038\/aps.2011.83","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,22]]}}}